References
- Abe, I., J. C. Tomesch, S. Wattanasin, and G. D. Prestwich. 1993. Inhibitors of squalene biosynthesis and metabolism. Nat. Prod. Rep. 11: 279-293 https://doi.org/10.1039/np9941100279
- Agnew, W. S. 1985. Squalene synthetase. Methods Enzymol. 110: 359-375 https://doi.org/10.1016/S0076-6879(85)10094-7
- Baxter, A., B. J. Fitzgerald, J. L. Hutson, A. D. McCarthy, J. M. Motteram, B. C. Ross, M. Sapra, M. A. Snowden, N. S. Watson, R. J. Williams, and C. Wright. 1992. Squalestatin, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. J. Biol. Chem. 267: 11705-11708
- Bergstrom, J. D., M. M. Krutz, D. J. Rew, A. M. Amend, J. D. Karkas, R. D. Bostedor, V. S. Bansal, C. Dufresns, F. L. V. Middleworth, O. D. Hensens, J. M. Liesch, D. L. Zinc, K. E. Wilson, J. Onishi, J. A. Milligan, G. Bills, L. Kaplan, M. O. Nallin, R. G. Jenskins, L. Huang, M. S. Meinz, L. Quinn, R. U. Burg, Y. L. Kong, S. Mochales, M. Mojena, I. Martin, F. Pelaez, M. T. Diez, and A. W. Albert. 1993. Zaragozic acids: A family of metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci. USA 90: 80-89
- Biller, S. A., C. Forster, E. M. Gordon, T. Harrity, L. C. Rich, J. Marretta, and C. P. Ciosek. Jr. 1991. Isoprenyl phosphinylformates: New inhibitors of squalene synthetase. J. Med. Chem. 34: 1912-1914 https://doi.org/10.1021/jm00110a024
- Cho, J.-Y., G. J. Choi, S.-W. Lee, K. S. Jang, H. K. Lim, C. H. Lim, S. O. Lee, K. Y. Cho, and J.-C. Kim. 2006. Antifungal activity against Colletotrichum spp. of curcuminoids isolated from Curcuma longa L. rhizomes. J. Microbiol. Biotechnol. 16: 280-285
- Cho, J.-Y., J.-H. Moon, H.-K. Kim, S.-J. Ma, S.-J. Kim, M.- Y. Jang, K. Kawazoe, Y. Takaishi, and K.-H. Park. 2006. Isolation and structural elucidation of antimicrobial compounds from buckwheat hull. J. Microbiol. Biotechnol. 16: 538-542
- Choi, S. W., D. S. Kim, N. Y. Hur, C. S. Park, and M. Y. Baik. 2003. Purification and identification of squalene synthase inhibitor isolated from fermented soybean paste. Food Sci. Biotechnol. 14: 89-93
- Dawson, M. J., J. E. Farthing, P. S. Marshall, R. F. Middleton, M. J. O'Neill, A. Shuttleworth, C. Stylli, R. M. Tait, P. M. Taylor, H. G. Wildman, A. D. Buss, D. Langley, and M. V. Hayes. 1992. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. J. Antibiot. 45: 639-647 https://doi.org/10.7164/antibiotics.45.639
- Feng, R., Y. Lu, L. L. Bowman, Y. Qian, V. Castranova, and M. Ding. 2005. Inhibition of activator protein-1, NFkappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J. Biol. Chem. 280: 27888-27895 https://doi.org/10.1074/jbc.M503347200
- Ha, C. G., J. K. Cho, C. H. Lee, Y. G. Chai, Y. A. Ha, and S. H. Shin. 2006. Cholesterol lowering effect of Lactobacillus plantarum isolated from human feces. J. Microbiol. Biotechnol. 16: 1201-1209
- Haria, M. and D. Mctavish. 1997. Pravastatin. Drugs 53: 299-336 https://doi.org/10.2165/00003495-199753020-00008
- Hiyoshi, H., M. Yanagimachi, M. Ito, I. Ohtsuka, I. Yoshida, T. Saeki, and H. Tanaka. 2000. Effect of ER- 27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: Comparison with 3-hydroxy- 3-methylglutaryl-CoA reductase inhibitors. J. Lipid Res. 41: 1136-1144
- Hiyoshi, H., M. Yanagimachi, M. Ito, T. Saeki, I. Yoshida, T. Okada, H. Ikuta, D. Shinmyo, K. Tanaka, N. Kurusu, and H. Tanaka. 2001. Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptorindependent mechanism. Eur. J. Pharmacol. 431: 345-352 https://doi.org/10.1016/S0014-2999(01)01450-9
- Huh, S. J., K. H. Lee, H. S. Yun, D. J. Paik, J. M. Kim, and J. H. Youn. 2007. Functions of metallothionein generating interleukin-10-producing regulatory CD4+ cells potentiate suppression of collagen induced arthritis. J. Microbiol. Biotechnol. 17: 348-358
- Ishihara, T., H. Kakuta, H. Moritani, T. Ugawa, S. Sakamoto, S. Tsukamoto, and I. Yanagisawa. 2003. Syntheses of 3-ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: Enzyme inhibition and effects on plasma lipid levels. Bioorg. Med. Chem. 11: 3735-3745 https://doi.org/10.1016/S0968-0896(03)00336-5
- Jee, H. J. 1999. Health Foods from Herbs, p. 52. Seoul National University Press, Seoul, Korea
- Kasim, S. E., R. C. Leboeuf, S. Khilnani, L. Tallapaka, D. Dayanada, and L. C. Jenk. 1992. Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat. J. Lipid Res. 33: 1-7
- Keller, R. K. and F. Vilsaint. 1993. Regulation of isoprenoid metabolism in rat liver: Near constant chain lengths of dolichy phosphate and ubiquinone are maintained during greatly altered rates of cholesterogenesis. Biochim. Biophy. Acta 1170: 20-25
- Koo, K.-C., D.-H. Lee, J.-H. Kim, H.-E. Yu, J.-S. Park, and J.-S. Lee. 2006. Production and characterization of antihypertensive angiotensin I-converting enzyme inhibitor from Pholiota adiposa. J. Microbiol. Biotechnol. 16: 757- 763
- Kuswik, R. G. and H. C. Rilling. 1987. Squalene synthetase. Solubilization and partial purification of squalene synthetase, copurification of presqualene pyrophosphate and squalene synthetase activities. J. Biol. Chem. 262: 1505-1510
- Lim, Y.-H., I.-H. Kim, J.-J. Seo, and J.-K. Kim. 2006. Tyrosinase inhibitor from the flowers of Impatiens balsamina. J. Microbiol. Biotechnol. 16: 1977-1983
- Lipid Research Clinics. 1984. Lipid research clinics program. J. Am. Med. Assoc. 252: 2545-2548 https://doi.org/10.1001/jama.252.18.2545
- McClellan, K. J., L. R. Wiseman, and D. McTavish. 1998. Cerivastatin. Drugs 55: 415-422 https://doi.org/10.2165/00003495-199855030-00009
- Nardini, M., F. Natella, V. Gentili, M. Di-Felice, and C. Scaccini. 1997. Effect of caffeic acid dietary supplementation on the antioxidant defense system in rat: An in vivo study. Arch. Biochem. Biophys. 342: 157-160 https://doi.org/10.1006/abbi.1997.9977
- Nishimoto, T., Y. Amano, R. Tozawa, E. Ishikawa, Y. Imura, H. Yukimasa, and Y. Sugiyama. 2003. Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro. Br. J. Pharmacol. 139: 911-918 https://doi.org/10.1038/sj.bjp.0705332
- Park, J. K., H. J. Cho, Y. H. Lim, Y. H. Cho, and C. H. Lee. 2002. Hypocholesterolemic effect of CJ90002 in hamsters: A potent inhibitor for squalene synthase from Paeonia moutan. J. Microbiol. Biotechnol. 12: 222-227
- Poulter, C. D. 1991. Biosynthesis of non-head-to-tail terpenes. Formation of 1'-1 and 1'-3 linkages. Acc. Chem. Res. 23: 70-77 https://doi.org/10.1021/ar00171a003
- Poulter, C. D. and H. C. Rilling. 1981. Biosynthesis of Isoprenoid Compounds, pp. 413-441. Wiley Publisher, New York, U.S.A
- Rodriguez, de Sotillo D. V. and M. Hadley. 2002. Chlorogenic acid modifies plasma and liver concentrations of cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J . Nutr. Biochem. 13: 717-726 https://doi.org/10.1016/S0955-2863(02)00231-0
- Shepherd, J., S. M. Cobbe, I. Ford, C. G. Isles, A. R. Lorimer, P. W. MacFarlane, J. H. McKillop, and C. J. Packard. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 333: 1301-1307 https://doi.org/10.1056/NEJM199511163332001
- Scandinavian Simvastatin Survival Study Group. 1994. Randomized trial of cholesterol-lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389